Back to Clinical Trials Overview

Back To Cancer Clinical Trials

Your search for "Breast" returned 11 results:


Phase II Trial of Combination Immunotherapy with Nelipepimut-S + GM-CSF (NeuVax™) and Trastuzumab in High Risk HER2+ Breast Cancer Patients
Principal Investigator(s): Dr. Amy Tiersten

Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmesis in Patients with Multiple Ipsilateral Breast Cancers
Principal Investigator(s): Elisa Port

A011106- ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study
Principal Investigator(s): Dr. Amy Tiersten

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant with or without LY2835219, a CDK4/6 Inhibitor, for Women with Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
Principal Investigator(s): Dr. Amy Tiersten

A Multi-Centered Randomized Phase II Comparison of Single-Agent Carboplatin versus the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
Principal Investigator(s): Dr. Amy Tiersten

Brief hypnosis intervention to control side effects associated with mastectomy with autologous breast reconstruction: A randomized clinical trial
Principal Investigator(s): Dr. Peter Taub

A Randomized Multicenter Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of Vaccination with Folate Receptor Alpha peptides with GM-CSF in patients with Triple Negative Breast Cancer
Principal Investigator(s): Dr. Amy Tiersten

Comparison of weight loss among early stage breast cancer patients post chemotherapy: nutrition education in combination with weight loss acupuncture vs. nutrition education alone
Principal Investigator(s): Dr. Amy Tiersten

Combination Immunotherapy with Herceptin and the HER2 Vaccine E75 in Low and Intermediate HER2 Expressing Breast Cancer Patients to Prevent Recurrence
Principal Investigator(s): Dr. Amy Tiersten

AN OPEN-LABEL, PHASE I/IIA STUDY OF GDC-0810 IN POSTMENOPAUSAL WOMEN WITH LOCALLY ADVANCED OR METASTATIC ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Principal Investigator(s): Dr. Charles Shapiro

Phase I/II Trial of Ruxolitinib in combination with Trastuzumab in Metastatic Her2 positive breast cancer
Principal Investigator(s): Dr. Amy Tiersten